Management of vesical dysfunction in multiple sclerosis.
Using urodynamic testing, vesical dysfunction in patients with multiple sclerosis can be classified and basic therapeutic principles outlined. Satisfactory voiding patterns can be achieved in most patients with multiple sclerosis without surgical procedures. Flexibility and willingness to change programs as the disease process changes make possible reasonably satisfactory results.
D001626:Bethanechol Compounds / Q000627:therapeutic use; D003975:Diazepam / Q000627:therapeutic use; D006801:Humans; D009103:Multiple Sclerosis / Q000150:complications*; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012021:Reflex, Abnormal / Q000188:drug therapy / Q000209:etiology; D001743:Urinary Bladder / Q000503:physiopathology*; D001745:Urinary Bladder Diseases / Q000188:drug therapy / Q000209:etiology*; D014563:Urodynamics
D001626:Bethanechol Compounds; D010643:Phenoxybenzamine; D003975:Diazepam